Development of the Drug Product Formulation of the Bevacizumab Biosimilar PF-06439535 (Bevacizumab-bvzr)
{{output}}
Background: PF-06439535 (bevacizumab-bvzr; Zirabev®) is a biosimilar of bevacizumab reference product (RP; Avastin®). This study describes the formulation development for PF-06439535. ... ...
